Although immune checkpoint inhibitors have shown noticeable clinical benefits, tumor evasion of single-agent immunotherapy occurs in some patients due to the compensatory role of alternative immune ...

The company identified PVRIG and TIGIT as immune checkpoints in the DNAM axis, an important signaling pathway in T- and NK-cell function, which led to the discovery and development of novel ...